$AHR

AMERICAN HEALTHCARE REIT ($AHR) Releases Q2 2026 Earnings

American Healthcare REIT (AHR) reported Q2 2026 earnings on Aug. 6. The company posted EPS of $0.54 versus an estimate of $0.17, and revenue of $670.96 million versus $669.80 million. The article also cites recent insider sales and institutional position changes, plus a median analyst price target of $57.

Original reporting
Published Aug 6, 2026, 10:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 4:28 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMERICAN HEALTHCARE REIT ($AHR) Releases Q2 2026 Earnings — source image
Decision brief

The 30-second read

$AHRBullishMed
01

Why it matters

AHR’s reported EPS and revenue both beat consensus, which is the only concrete, decision-relevant datapoint for trading in this text. Insider sales and mixed institutional flows are secondary and lack enough detail to override the earnings signal.

02

Market read

Traders can use the reported EPS and revenue beats as the immediate catalyst, but the lack of guidance and REIT-specific metrics limits conviction on follow-through.

03

What to watch

The article omits guidance, FFO/AFFO, occupancy, lease-up, interest-rate sensitivity, and capital-structure details that typically drive REIT trading after earnings.

Relevance 8/10Novelty 8/10Timing: reported after close on Aug 6, 2026

Background

The piece is a Quiver Quantitative earnings write-up for American Healthcare REIT’s Q2 2026 results, plus ancillary insider and institutional activity.

Company-level read

Ticker impact

$AHRBullishMedium confidence
Context

American Healthcare REIT reported Q2 2026 EPS of $0.54, beating $0.17 estimates, and revenue of $670.96M, beating estimates.

Expected impact

Likely positive near-term reaction, with follow-through depending on whether the beat reflects sustainable operating trends versus one-offs.

Evidence & confidence

The article provides only headline EPS and revenue beats versus estimates, with no guidance, margins, or balance-sheet details to assess durability or magnitude of surprise.

Market effects

A beat from a healthcare REIT can modestly support the sector’s earnings narrative, though no peer-specific read-across is provided here.

No regional demand or portfolio concentration details are disclosed.

No global macro or cross-border financing impacts are mentioned.

Counterpoint

A headline EPS and revenue beat may not translate into sustained outperformance if it is driven by non-recurring items or temporary occupancy/rent timing.

Key entities

  • American Healthcare REIT

    Subject of the article, reporting Q2 2026 earnings with EPS and revenue beats versus estimates.

  • Brian Peay

    CFO who sold 25,000 shares in the past 6 months per the article.

Related articles

$AHRMed

American Healthcare REIT Continues ‘Next Level of Growth’ With SHOP Deals

American Healthcare REIT (AHR) raised its projected investment pipeline to $800 million from $650 million (May). In Q2, it completed $126.9 million of SHOP investments, taking yearly SHOP investments to $1.4 billion. Same-store SHOP NOI grew 20.5% y/y. AHR also reported a $197.5 million in-process development and expansion pipeline, with $72 million funded, and its stock rose 3.71% to $56.74.

$AHRMedAI 8/10

American Healthcare REIT Posts Strong Q2 2026 Results; Raises Full Year 2026 Guidance

American Healthcare REIT reported Q2 2026 GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, and NFFO attributable to controlling interest of $0.54 per diluted share. Same-store NOI rose 13.2% YoY. The company raised FY 2026 guidance, including NFFO per diluted share to $2.15-$2.19, and declared a $0.25 quarterly common dividend.

$AHRLow

American Healthcare REIT, Inc. (AHR): Results of Operations and Financial Condition

American Healthcare REIT, Inc. (AHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 ahr-ex99_2.htm EX-99.2 EX-99.2 Second Quarter 2026 Supplemental Talamore Senior Living Sun Prairie, WI Exhibit 99.2 Disclaimers Forward-Looking Statements Certain statements contained in this supplemental, filed in conjunction with the Second Quarter 2026 Earnings Press

$AHRMedAI 9/10

BofA Raises its Price Target on American Healthcare REIT (AHR)

On May 22, 2026, BofA raised its price target for American Healthcare REIT (AHR) to $67 from $63 and kept a Buy rating, saying it updated REIT models. AHR also announced a May 20 underwritten offering of 14M shares priced at $50.40. In Q1, normalized FFO was 50c (vs 47c consensus) and revenue was $650.77M (below $687.04M).